Relation of the aortic stiffness with the GRACE risk score in patients with the non ST-segment elevation myocardial

Gedikli Omer1, Aksan Gokhan2, Uzun Adem1

  • 1Departmant of Cardiology, Artvin State Hospital Artvin, Turkey.

Insights

Aortic stiffness is linked to higher Global Registry of Acute Coronary Events (GRACE) risk scores in Non-ST-elevation myocardial infarction (NSTEMI) patients. Measuring aortic stiffness may improve risk assessment for acute coronary syndrome (ACS).

Area of Science:

  • Cardiology
  • Vascular Physiology
  • Medical Diagnostics

Background:

  • Clinical risk scores guide treatment for Non-ST-elevation myocardial infarction (NSTEMI).
  • Aortic elasticity and stiffness are associated with Coronary Artery Disease (CAD) severity.
  • The relationship between aortic stiffness and clinical risk scores in NSTEMI is not well-established.

Purpose of the Study:

  • To investigate the association between aortic stiffness and the Global Registry of Acute Coronary Events (GRACE) risk score in NSTEMI patients.
  • To determine if aortic stiffness can serve as an independent predictor of high GRACE risk scores.

Main Methods:

  • Prospective analysis of 87 NSTEMI patients.
  • Calculation of aortic elastic and stiffness parameters using echocardiography and sphygmomanometry.
  • Categorization into low (GRACE ≤ 140) and high (GRACE > 140) risk groups.

Main Results:

  • High-risk patients exhibited significantly lower aortic strain and higher aortic stiffness index compared to low-risk patients (p < 0.001).
  • Aortic stiffness index was the sole independent predictor of GRACE risk score in multivariate analysis (OR: 119.390; p = 0.011).

Conclusions:

  • A significant correlation exists between aortic stiffness, impaired elasticity, and GRACE risk score in NSTEMI.
  • Aortic stiffness index independently predicts high GRACE risk scores.
  • Incorporating aortic stiffness into risk scores may enhance risk classification for Acute Coronary Syndrome (ACS) patients.
Abstract

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
580
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
1.5K
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
1.1K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
604
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
490
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
948